These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2141672)

  • 1. The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction.
    Searl T; Prior C; Marshall IG
    Neuroscience; 1990; 35(1):145-56. PubMed ID: 2141672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post- and presynaptic effects of vesamicol (AH5183) on the frog neuromuscular junction.
    Enomoto K
    Eur J Pharmacol; 1988 Mar; 147(2):209-15. PubMed ID: 3366175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storage.
    Whitton PS; Marshall IG; Parsons SM
    Brain Res; 1986 Oct; 385(1):189-92. PubMed ID: 3768717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T; Prior C; Marshall IG
    J Physiol; 1991 Dec; 444():99-116. PubMed ID: 1668355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.
    Estrella D; Green KL; Prior C; Dempster J; Halliwell RF; Jacobs RS; Parsons SM; Parsons RL; Marshall IG
    Br J Pharmacol; 1988 Apr; 93(4):759-68. PubMed ID: 3260527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
    Arenson MS; Evans SC
    Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA; Van der Kloot W
    J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions.
    Pemberton KE; Prior C; Marshall IG
    Br J Pharmacol; 1992 Jan; 105(1):113-8. PubMed ID: 1375854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
    Hong SJ; Lee SH; Chang CC
    Neuroscience; 1995 Jul; 67(1):169-75. PubMed ID: 7477897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
    Vizi ES
    Br J Pharmacol; 1989 Nov; 98(3):898-902. PubMed ID: 2590773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nerve terminal activity on non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Zemková H; Vyskocil F; Edwards C
    J Physiol; 1990 Apr; 423():631-40. PubMed ID: 2388160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of veratridine on miniature endplate current amplitudes at the rat neuromuscular junction and acetylcholine uptake by Torpedo synaptic vesicles.
    Pemberton KE; Nguyen ML; Prior C; Parsons SM; Marshall IG
    Brain Res; 1995 Feb; 671(2):267-74. PubMed ID: 7743214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT
    Brain Res; 1988 Sep; 461(1):118-26. PubMed ID: 3265645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic and postsynaptic effects of the venom of the Australian tiger snake at the neuromuscular junction.
    Datyner ME; Gage PW
    Br J Pharmacol; 1973 Oct; 49(2):340-54. PubMed ID: 4367126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of vesamicol binding sites and frequency augmentation-potentiation in neuromuscular transmission.
    Maeno T; Enomoto K; Sawada M; Ichinose M
    Jpn J Physiol; 1994; 44(6):705-16. PubMed ID: 7760524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.